ALASTIN Skincare Inc, a specialty aesthetics company dedicated to developing and marketing clinically tested physician-dispensed skin care products, announces that the United States Patent and Trademark Office has issued two new patents, bringing the total number of ALASTIN US patents to six, along with a seventh patent issued in Canada.

U.S. Patent No.11,052,032 covers ALASTIN’s platform TriHex Technology and US Patent No. 11,103,455 relates to liposomal compositions, both associated with TransFORM Body Treatment. These new patents are directed to methods for the use of topical compositions of TransFORM Body Treatment with TriHex Technology to improve skin laxity, texture or crepiness, with or without body contouring procedures or for targeting dermal white adipose tissue, the company notes in a media release.

“We are immensely proud of the scientific rigor we have established in validating the TriHex Technology performance in our product formulations, which is confirmed by our numerous patents. This is particularly relevant to this TransFORM Body product where disruptive new science has allowed us to make great progress in aiding skin tightening and body contouring.”

— Dr. Alan Widgerow, MBBCh (MD); MMed (MHS); FCS; FACS and Chief Medical Officer at ALASTIN

TransFORM Body Treatment with TriHex Technology was launched in 2018 and has been recognized for its demonstrated clinical efficacy, both as a complement to popular non-invasive body contouring procedures to support the body’s natural repair processes, and on its own for its proven skin smoothing effects, per the release.

[Source(s): ALASTIN Skincare Inc, PR Newswire]

Related Content:
Study Highlights Results of ALASTIN Skincare’s TransFORM Body Treatment with TriHex Technology
ALASTIN Skincare Launches INhance Post-Injection Serum with TriHex Technology
ALASTIN Receives 4th Patent for Its TriHex Technology